On November 5, Emerson fell 3.15% in Regular Trading, trading at $164.52 with turnover of $102 million.
The clearest catalyst is the market reaction to the company’s latest outlook after its quarterly results, even as Bernstein raised its price target to $196 from $186.
Emerson reported fiscal fourth-quarter net sales of $5.20 billion, up 7% year over year and above the $5.11 billion consensus, while adjusted EPS of $1.86 edged past the $1.85 expectation. Underlying orders rose 14%, a key operational highlight. However, fiscal first-quarter adjusted EPS guidance of $1.58 to $1.62 and fiscal 2027 adjusted EPS guidance of about $7.25 were at or slightly below consensus expectations, which appears to have limited enthusiasm and weighed on the shares despite the analyst target increase.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments